Aspreva Pharmaceuticals Raises $113 Million in Initial Public Offering

Aspreva Pharmaceuticals Corp. has raised $113.3 million in its initial public offering. The Victoria-based drug developer said it has closed its offering of 8.28 million shares at a price of $13.68 per share. The shares are listed on the Nasdaq and the Toronto Stock Exchange. Aspreva Pharmaceuticals is focused on identifying, developing and commercializing alternative uses for approved drugs for underserved patient groups.

Yahoo News (http://news.yahoo.com/news?tmpl=story&u=/cpress/20050309/ca_pr_on_tc/aspreva_pharmaceuticals_1)